Expands access to Fresenius Medical Care's globally established portfolio of advanced kidney replacement therapies in the U.S ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, presents new research ...

Jonathon Lawrence, Managing Director UK&I at Fresenius, says the dialysis centre will put “lower-carbon design at the heart of kidney care infrastructure” ...

Fresenius Medical Care Presents New Research And Evidence-Driven Innovations Aimed At Improving Patient Outcomes During ASN Kidney Week 2026 CI Oct. 19 Fresenius Medical Care AG : Deutsche Bank ...

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, ...

Fresenius Medical Care AG is the world's leading supplier of services and equipment for patients with kidney problems. Net sales break down by activity as follows: - clinical care services (75.2%): ...

Fresenius Medical Care is improving operationally, with Q2 2026 organic revenue up 5% and adjusted operating profit up 23%. Read why FMS stock is a hold.

Fresenius Medical Care is presenting U.S. clinical research and technology-focused studies at ASN Kidney Week 2026 in Denver, October 21–25. Findings include real-world delivery ...

Fresenius Medical Care AG (FME.DE, FME) announced that Shervin J. Korangy will become Chief Executive Officer (CEO) and Chair of the Management Board, effective October 12, 2026. He will succeed Helen ...

The warning letter follows a summer of multiple recalls for Fresenius Kabi. Injectables juggernaut Fresenius Kabi has been hit with an FDA warning letter, the second for the Fresenius group in less ...